Major Program
Supportive Care and Symptom Management
Research Group
Community Oncology and Prevention Trials
Sponsor
M.D. Anderson Cancer Center
Status
Active, not recruiting
NCT ID
NCT03367156
This phase II trial studies how well dexamethasone works in controlling dyspnea in patients with cancer. Dexamethasone may help control dyspnea (shortness of breath) and improve lung function and quality of life in cancer patients.
Intervention
Dexamethasone, Questionnaire Administration, Placebo
Condition
Dyspnea, Malignant Neoplasm
Investigators
David Hui